The BBB (blood brain barrier) protects the brain but it also impedes the transport of neuropharmaceuticals into the brain. cOFM is a unique tool to investigate brain pharmacokinetics (PK) and pharmacodynamics (PD) with an intact BBB in preclinical studies. cOFM studies provide data for drug development as well as unique insights into brain metabolism and signaling.
All other regions
France, Switzerland
North-, Central-, South America, Japan, China, South Korea, Hong Kong, Singapur, Australia, Russia, Isreal, India
Ino nsiu listusno se letto in Redivio no lemi sie momente
Holoseto heli.
Ino nsiu listusno se letto in Redivio no lemi sie momente
Holoseto heli.
Ino nsiu listusno se letto in Redivio no lemi sie momente
Holoseto heli.
I am an introductory text. Sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum.
Get in touch with us
